Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 11, 2025International Journal of Molecular SciencesOpen Access

Focal Segmental Glomerulosclerosis: Comprehensive Review and Exploration of the Dual Potential of Cyclodextrins in Therapeutic Optimization

View Full Paper
Ask AI
Bookmark
Share

Authors

FMFilipa Mascarenhas‐MeloBMBruna de Almeida MartinsIMInês Monteiro

Discussion

Loading...

Member takes

Overview

Comprehensive review discusses cyclodextrins' potential in reducing podocyte injury and managing proteinuria in focal segmental glomerulosclerosis.

Key Points

  • Cyclodextrins may reduce proteinuria and improve renal function in focal segmental glomerulosclerosis.
  • Preclinical studies indicate that cyclodextrins alleviate podocyte injury by enhancing cholesterol efflux.
  • The pathophysiology of focal segmental glomerulosclerosis involves diverse mechanisms including lipid disturbances.
  • Current treatments for focal segmental glomerulosclerosis show variable effectiveness, emphasizing the need for novel strategies.

Cite This Study

Mascarenhas‐Melo et al. (2025) studied this question.

synapsesocial.com/papers/68d41720713b0b5dfea63426https://doi.org/10.3390/ijms26188760
View Full Paper
Ask AI
Bookmark
Share